drugset
drugset / Trial / NCT05202912

Food Effect Study of IDX-1197 in Healthy Subjects

NCT05202912 ↗

Phase 1 Completed 37 enrolled Idience Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

Study to Evaluate the Effects of Food or Ethnicity on the Pharmacokinetics and Safety/Tolerability of IDX-1197 After Single Oral Administration in Healthy Male Korean, Chinese, and Caucasian Volunteers

Timeline

Start
2022-01-16
Primary completion
2022-07-23
Completion
2022-07-23

Drugs

EvaluationDrugModalityDoseRoute
Subject IDX-1197 Unknown — Oral

Indications

No indication recorded.